News: Critics Favor Disclosing More Clinical Data on New Drug Risks

Drug regulators are being accused of being more concerned with protecting the profits of pharmaceutical companies than safeguarding the lives of patients.

The charge comes from doctors who spent three years battling with the European Medicines Agency (EMA) to extract the results of clinical trials carried out by drug companies on anti-obesity pills. The EMA, which gave the drugs a marketing licence, refused the requests.

Continue reading...

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments